Roseola (Exanthem subitum)

Roseola (exanthem subitum) is presented in the source payload as a recognized disease topic under the viral category, with variant naming that includes roseola infantum and exanthem subitum ^[1][2][3][4]. The available evidence consists only of scholarly metadata and title-level references, so the etiologic agent or formal case definition is not specified in the provided snippets ^[1][2][3][4].

Source-backed clinical description is not yet available in the provided material ^[1][2][3][4]. Although the titles indicate a condition associated with exanthem subitum and roseola infantum, the snippets do not describe symptom sequence, rash characteristics, fever pattern, severity, complications, or course ^[1][2][3][4]. No supported statements can be made here about age distribution, duration, or clinical red flags ^[1][2][3][4].

The supplied sources do not provide geographic distribution, incidence, outbreak context, seasonality, reservoir, or surveillance burden for roseola ^[1][2][3][4]. The disease is referenced in multiple scholarly publications spanning 1951, 2019, 2020, and 2024, which indicates it has been treated as a recurring clinical topic in the literature, but the snippets do not quantify frequency or public-health impact ^[1][2][3][4]. No source-backed epidemiologic pattern beyond these publication records is available ^[1][2][3][4].

The provided snippets do not state how roseola is transmitted or what exposure mechanisms are involved ^[1][2][3][4]. No source-backed information is available on respiratory spread, contact transmission, infectious period, or environmental persistence ^[1][2][3][4].

The provided sources do not identify any specific age, clinical, household, or exposure risk groups for roseola ^[1][2][3][4]. Source-backed detail is not yet available, so no group-specific susceptibility statement can be made from the current payload ^[1][2][3][4].

No prevention or exposure-control measures are described in the supplied sources ^[1][2][3][4]. Source-backed detail is not yet available on isolation, hygiene measures, vaccination, or other control strategies ^[1][2][3][4].

For surveillance use, this entry should be read as a named viral disease concept with alias variation across roseola, roseola infantum, and exanthem subitum in the source record ^[1][2][3][4]. Because the payload contains only bibliographic metadata and no syndromic or laboratory surveillance descriptors, classification, trend interpretation, and burden assessment require additional source material ^[1][2][3][4].

1. 1 Roseola (Exanthem Subitum). Family Practice Guidelines. 2020. doi: 10.1891/9780826153425.0016o. DOI: https://doi.org/10.1891/9780826153425.0016o
2. 2 Roseola infantum (Exanthem subitum). The Journal of Pediatrics. 1951. doi: 10.1016/s0022-3476(51)80214-2. DOI: https://doi.org/10.1016/s0022-3476(51)80214-2
3. 3 Roseola Infantum (Exanthem Subitum). The APRN and PA’s Complete Guide to Prescribing Drug Therapy. 2019. doi: 10.1891/9780826179357.0346. DOI: https://doi.org/10.1891/9780826179357.0346
4. 4 Exanthem Subitum, Roseola. Dermatology Diaries. 2024. doi: 10.1007/978-981-97-1578-7_16. DOI: https://doi.org/10.1007/978-981-97-1578-7_16

ICD-10

ICD-11

Total cases

874K

Peak month

2013-06

Coverage

1 reporting countries · 2012-09-15 → 2026-06-20